Middle income | Immunization, DPT (% of children ages 12-23 months)
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Middle income
Records
63
Source
Middle income | Immunization, DPT (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
11.37395903 1980
12.77761612 1981
15.39750483 1982
32.37277619 1983
39.6403508 1984
44.78582148 1985
47.92329882 1986
52.66787441 1987
63.41928642 1988
68.58264017 1989
77.02841459 1990
73.08033248 1991
71.61139476 1992
71.22087166 1993
73.81066361 1994
74.14048988 1995
73.07118985 1996
72.61923195 1997
73.38903709 1998
72.96550519 1999
73.34621026 2000
73.83428043 2001
73.22908498 2002
74.66565138 2003
76.60144597 2004
76.99262783 2005
78.37085972 2006
78.13754942 2007
81.43053588 2008
83.60018686 2009
84.26244156 2010
85.29297918 2011
85.29245631 2012
85.01489476 2013
85.79002194 2014
86.01349208 2015
87.25870338 2016
87.18736298 2017
88.06026265 2018
87.99553036 2019
84.41574876 2020
82.82831447 2021
86.82941651 2022
Middle income | Immunization, DPT (% of children ages 12-23 months)
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Middle income
Records
63
Source